Acadia Healthcare Announces Launch of $450 Million Senior Notes Offering
June 10 2020 - 8:55AM
Business Wire
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
(the “Company” or “Acadia”) announced today that it has launched a
private offering (the “Offering”) of senior notes due 2028 (the
“Notes”), subject to customary and market conditions.
The Company intends to use the net proceeds from the Offering,
together with cash on hand, to redeem in full its outstanding
6.125% Senior Notes due 2021 (the “2021 Notes”) and 5.125% Senior
Notes due 2022 (the “2022 Notes” and together with the 2021 Notes,
the “Existing Notes”) and to pay related fees and expenses in
connection therewith.
The Notes have not been registered under the Securities Act of
1933, as amended (the “Securities Act”), any state securities laws
or the securities laws of any other jurisdiction, and may not be
offered or sold in the United States, or for the benefit of U.S.
persons, except pursuant to an applicable exemption from, or in a
transaction not subject to, the registration requirements of the
Securities Act and applicable state securities or blue sky laws.
Accordingly, the Notes are being offered only to persons reasonably
believed to be “qualified institutional buyers,” as that term is
defined under Rule 144A of the Securities Act, or outside the
United States to non-“U.S. persons” in accordance with Regulation S
under the Securities Act.
A confidential offering memorandum for the Offering of the
Notes, dated as of today, is being made available to such eligible
persons. The Offering is being conducted in accordance with the
terms and subject to the conditions set forth in such confidential
offering memorandum.
This press release shall not constitute an offer to sell, a
solicitation to buy or an offer to purchase or sell any securities.
No offer, solicitation, purchase or sale will be made in any
jurisdiction in which such offer, solicitation or sale would be
unlawful. Any offer, or solicitation to buy, if at all, will be
made only by means of a confidential offering memorandum. This
press release does not constitute a notice to redeem the Existing
Notes.
About Acadia
Acadia is a leading provider of behavioral healthcare services.
As of March 31, 2020, Acadia operated a network of 588 behavioral
healthcare facilities with approximately 18,200 beds in 40 states,
the United Kingdom and Puerto Rico. Acadia provides behavioral
health and addiction treatment services to its patients in a
variety of settings, including inpatient psychiatric hospitals,
specialty treatment facilities, residential treatment centers and
outpatient clinics. Acadia also offers anyone in need of mental
health or addiction services a free, national behavioral health
crisis line at 1-833-TREATBH (873-2824).
Forward-Looking Information
This press release contains forward-looking statements.
Generally, words such as “may,” “will,” “should,” “could,”
“anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,”
and “believe” or the negative of or other variation on these and
other similar expressions identify forward‑looking statements.
These forward-looking statements are made only as of the date of
this press release. We do not undertake to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise. Forward-looking statements are based on
current expectations and involve risks and uncertainties and our
future results could differ significantly from those expressed or
implied by our forward-looking statements. The forward‑looking
statements contained in this press release include statements
related to the Offering and the use of proceeds therefrom. Factors
that may cause actual results to differ materially include, without
limitation, (i) the impact of the COVID‑19 pandemic; (ii) Acadia’s
ability to implement its business strategies in the U.S. and the
U.K.; (iii) potential difficulties operating our business in light
of political and economic instability in the U.K. and globally
relating to the U.K.’s departure from the European Union; (iv) the
impact of fluctuations in foreign exchange rates, including the
devaluation of the British Pound Sterling (GBP) relative to the
U.S. Dollar (USD); (v) Acadia’s efforts to sell its U.K. operations
may not result in any definitive transaction or enhance stockholder
value, if Acadia decides to pursue such a transaction in the
future; (vi) potential difficulties in successfully integrating the
operations of acquired facilities or realizing the expected
benefits and synergies of our acquisitions, joint ventures and de
novo transactions; (vii) Acadia’s ability to add beds, expand
services, enhance marketing programs and improve efficiencies at
its facilities; (viii) potential reductions in payments received by
Acadia from government and commercial payors; (ix) the occurrence
of patient incidents, governmental investigations and adverse
regulatory actions, which could adversely affect the price of our
common stock and result in substantial payments and incremental
regulatory burdens; (x) Acadia’s significant debt and the
restrictive covenants contained therein and otherwise in its
agreements, which may restrict its business and financing
activities; (xi) the risk that Acadia may not generate sufficient
cash from operations to service its debt and meet its working
capital and capital expenditure requirements; (xii) potential
operating difficulties, labor costs, client preferences, laws and
regulations, interpretations of accounting principles or recent tax
legislation, changes in competition and general economic or
industry conditions that may prevent Acadia from realizing the
expected benefits of its business strategies; and (xiii) the impact
of governmental investigations, regulatory actions and
whistleblower lawsuits. These factors and others are more fully
described in Acadia’s Annual Report on Form 10-K for the year ended
December 31, 2019, its Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2020 and subsequent periodic
reports and other filings with the SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200610005439/en/
Gretchen Hommrich Director, Investor Relations (615)
861-6000
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From May 2024 to Jun 2024
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Jun 2023 to Jun 2024